SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-022780
Filing Date
2023-08-09
Accepted
2023-08-09 16:05:33
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20230630_10q.htm   iXBRL 10-Q 747899
2 EXHIBIT 31.1 ex_552801.htm EX-31.1 11313
3 EXHIBIT 31.2 ex_552802.htm EX-31.2 11687
4 EXHIBIT 32.1 ex_552803.htm EX-32.1 4375
5 EXHIBIT 32.2 ex_552804.htm EX-32.2 4677
  Complete submission text file 0001437749-23-022780.txt   4028309

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcda-20230630.xsd EX-101.SCH 42935
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20230630_def.xml EX-101.DEF 280736
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20230630_lab.xml EX-101.LAB 238616
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20230630_pre.xml EX-101.PRE 304451
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20230630_cal.xml EX-101.CAL 28805
55 EXTRACTED XBRL INSTANCE DOCUMENT bcda20230630_10q_htm.xml XML 551569
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 231155087
SIC: 2836 Biological Products, (No Diagnostic Substances)